Mendez
Mendez v. Global Institute Of Stem Cell Therapy And Research, USA
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 CHRISTINA MENDEZ, individually and Case No.: 20cv915-LL-BLM on behalf of all others similarly situated,
ORDER DISMISSING COMPLAINT
Plaintiff, WITH LEAVE TO AMEND AND v. DENYING MOTION TO DISMISS
AS MOOT
GLOBAL INSTITUTE OF STEM CELL
15 THERAPY AND RESEARCH, USA, et [ECF Nos. 15, 16] al.,
Defendants. 18 19 In this putative consumer class action, Plaintiff Christina Mendez alleges federal jurisdiction on the basis of the Class Action Fairness Act of 2005, 28 U.S.C. § 1332(d) (“CAFA”). ECF No. 15. Pending before the Court is Plaintiff’s operative First Amended Complaint (“FAC”), id., and a Motion to Dismiss the FAC filed by Global Institute of Stem Cell Therapy and Research, USA (“Giostar”), Giostar Labs, Inc. (“Giostar Labs”), Anand Srivastava, Deven Patel, Siddharth Bhavsar, and Scott Kirkpatrick (together, “Defendants”), ECF No. 16. For the reasons discussed below, this action is DISMISSED 27 …